BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38736635)

  • 1. Dietary management for pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency, a follow-on from the international consortium guidelines.
    Dixon M; Millington C; Bernstein L; Coughlin CR; Drumm M; Gaughan S; van Karnebeek CDM; van Wegberg AMJ
    JIMD Rep; 2024 May; 65(3):188-203. PubMed ID: 38736635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision.
    Boy N; Mühlhausen C; Maier EM; Ballhausen D; Baumgartner MR; Beblo S; Burgard P; Chapman KA; Dobbelaere D; Heringer-Seifert J; Fleissner S; Grohmann-Held K; Hahn G; Harting I; Hoffmann GF; Jochum F; Karall D; Konstantopoulous V; Krawinkel MB; Lindner M; Märtner EMC; Nuoffer JM; Okun JG; Plecko B; Posset R; Sahm K; Scholl-Bürgi S; Thimm E; Walter M; Williams M; Vom Dahl S; Ziagaki A; Zschocke J; Kölker S
    J Inherit Metab Dis; 2023 May; 46(3):482-519. PubMed ID: 36221165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine.
    Kim J; Pipitone Dempsey A; Kim SY; Gunay-Aygun M; Vernon HJ
    Case Rep Genet; 2022; 2022():7138435. PubMed ID: 36082373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy.
    Coughlin CR; Tseng LA; Bok LA; Hartmann H; Footitt E; Striano P; Tabarki BM; Lunsing RJ; Stockler-Ipsiroglu S; Gordon S; Van Hove JLK; Abdenur JE; Boyer M; Longo N; Andrews A; Janssen MCH; van Wegberg A; Prasad C; Prasad AN; Lamb MM; Wijburg FA; Gospe SM; van Karnebeek C;
    Neurology; 2022 Dec; 99(23):e2627-e2636. PubMed ID: 36008148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes.
    Tseng LA; Teela L; Janssen MC; Bok LA; Willemsen MAAP; Neuteboom RF; Haverman L; Gospe SM; Coughlin CR; van Karnebeek CDM
    Mol Genet Metab Rep; 2022 Jun; 31():100853. PubMed ID: 35782612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Reasoning: Pediatric Seizures of Unknown Cause.
    Tseng LA; Hoytema van Konijnenburg EMM; Longo N; Andrews A; van Wegberg A; Coene KLM; Coughlin CR; van Karnebeek CDM
    Neurology; 2022 Jun; 98(24):1023-1028. PubMed ID: 35470136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy.
    Tseng LA; Abdenur JE; Andrews A; Aziz VG; Bok LA; Boyer M; Buhas D; Hartmann H; Footitt EJ; Grønborg S; Janssen MCH; Longo N; Lunsing RJ; MacKenzie AE; Wijburg FA; Gospe SM; Coughlin CR; van Karnebeek CDM
    Mol Genet Metab; 2022 Apr; 135(4):350-356. PubMed ID: 35279367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case for newborn screening for pyridoxine-dependent epilepsy.
    Coughlin CR; Tseng LA; van Karnebeek CDM
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35217564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Diagnosis of Pyridoxine-Dependent Epilepsy in Two Adolescent Siblings.
    Işıkay S
    Ann Indian Acad Neurol; 2021; 24(5):770-771. PubMed ID: 35002142
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross-sectional study.
    Strijker M; Tseng LA; van Avezaath LK; Oude Luttikhuis MAM; Ketelaar T; Coughlin CR; Coenen MA; van Spronsen FJ; Williams M; de Vries MC; Westerlaan HE; Bok LA; van Karnebeek CDM; Lunsing RJ
    Eur J Paediatr Neurol; 2021 Jul; 33():112-120. PubMed ID: 34153871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.
    Engelke UF; van Outersterp RE; Merx J; van Geenen FA; van Rooij A; Berden G; Huigen MC; Kluijtmans LA; Peters TM; Al-Shekaili HH; Leavitt BR; de Vrieze E; Broekman S; van Wijk E; Tseng LA; Kulkarni P; Rutjes FP; Mecinović J; Struys EA; Jansen LA; Gospe SM; Mercimek-Andrews S; Hyland K; Willemsen MA; Bok LA; van Karnebeek CD; Wevers RA; Boltje TJ; Oomens J; Martens J; Coene KL
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34138754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
    Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM
    J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical outcome of a patient with pyridoxine-dependent epilepsy treated by triple therapy (pyridoxine supplementation, lysine-restricted diet, and arginine supplementation).
    Minet P; Sarret C; Miret A; Mention K; Benoist JF; Remerand G
    Acta Neurol Belg; 2021 Dec; 121(6):1669-1675. PubMed ID: 33113107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.
    Kava MP; Bryant L; Rowe P; Lewis B; Greed L; Balasubramaniam S
    JIMD Rep; 2020 Jul; 54(1):9-15. PubMed ID: 32685344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKU dietary handbook to accompany PKU guidelines.
    MacDonald A; van Wegberg AMJ; Ahring K; Beblo S; Bélanger-Quintana A; Burlina A; Campistol J; Coşkun T; Feillet F; Giżewska M; Huijbregts SC; Leuzzi V; Maillot F; Muntau AC; Rocha JC; Romani C; Trefz F; van Spronsen FJ
    Orphanet J Rare Dis; 2020 Jun; 15(1):171. PubMed ID: 32605583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of enteral arginine supplementation on lysine metabolism in humans: A proof-of-concept for lysine-related inborn errors of metabolism.
    Schmidt Z; Murthy G; Ennis M; Stockler-Ipsiroglu S; Elango R
    J Inherit Metab Dis; 2020 Sep; 43(5):952-959. PubMed ID: 32187681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of Tryptophan Analysis by Liquid Chromatography-Single Quadrupole Mass Spectrometry Through the Evaluation of Multiple Parameters.
    la Cour R; Jørgensen H; Schjoerring JK
    Front Chem; 2019; 7():797. PubMed ID: 31803725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel biomarker for pyridoxine-dependent epilepsy: Implications for newborn screening.
    Wempe MF; Kumar A; Kumar V; Choi YJ; Swanson MA; Friederich MW; Hyland K; Yue WW; Van Hove JLK; Coughlin CR
    J Inherit Metab Dis; 2019 May; 42(3):565-574. PubMed ID: 30663059
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.